| Related Articles |
Antibodies increase the risk of poor outcome for patients with autoimmune hepatitis.
Nurs Stand. 2015 Sep 9;30(2):14
Authors:
Abstract
The presence of antibodies for the soluble liver antigen/liver pancreas antigen (SLA/LP) is a major risk factor for poor outcomes in patients with autoimmune hepatitis, say German researchers.
PMID: 26350841 [PubMed – in process]
http://www.ncbi.nlm.nih.gov/pubmed/26350841?dopt=Abstract